28th February 2023
The paper discussed in today's episode: Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results
27th January 2023
According to the World Health Organization, of the roughly 10 million people who fall ill with TB annually, over 80% survive.
Unfortunately, as with long Covid, being cured of TB is not always the last hurdle and many people go on to struggle with post-TB lung disease.
Tiyese Jeranji asked local experts about this sometimes-neglected area of TB care.
26th May 2022
Prof Rodney Dawson speaks to Refilwe Moloto about a new trial involving BTZ-043
25th May 2022
Are you interested in taking part in a COVID-19 research study? Participants are required for the Covidity vaccine.
19th May 2022
BTZ-043 was profiled in an early phase development study at the UCTLI, sponsored by the EDCTP and German funds in 2019
29th April 2022
UCT Lung Institute in partnership with Novartis and the Department of Health launched a ‘lab-in-a-cab’ mobile TB clinic
28th April 2022
Prof Rod Dawson, Managing Director of the UCT Lung Institute attends the handover of two Ford Custom Transporter vehicles from Mekor Ford Claremont
7th April 2022
UCT Lung Institute prides itself in having a strong partnership with the community we serve
10th January 2022
The first to study the efficacy of mRNA COVID-19 vaccines in people living with HIV
25th September 2019
3rd June 2019
June 03, 2019 09:00 AM Eastern Daylight Time SEONGNAM-SI, South Korea–(BUSINESS WIRE)–Qurient Co. Ltd. today announced positive results from the Phase 2a EBA (early […]
23rd April 2019
